Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer
Titel:
Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer
Auteur:
Buzdar, A. Hayes, D. El-Khoudary, A. Yan, S. Lønning, P. Lichinitser, M. Gopal, R. Falkson, G. Pritchard, K. Lipton, A. Wolter, K. Lee, A. Fly, K. Chew, R. Alderdice, M. Burke, K. Eisenberg, P.